179 related articles for article (PubMed ID: 27305093)
1. Prognostic Role of Mucin Antigen MUC4 for Cholangiocarcinoma: A Meta-Analysis.
Li B; Tang H; Zhang A; Dong J
PLoS One; 2016; 11(6):e0157878. PubMed ID: 27305093
[TBL] [Abstract][Full Text] [Related]
2. Prognostic biomarkers in patients with resected cholangiocarcinoma: a systematic review and meta-analysis.
Ruys AT; Groot Koerkamp B; Wiggers JK; Klümpen HJ; ten Kate FJ; van Gulik TM
Ann Surg Oncol; 2014 Feb; 21(2):487-500. PubMed ID: 24081803
[TBL] [Abstract][Full Text] [Related]
3. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
Shibahara H; Tamada S; Higashi M; Goto M; Batra SK; Hollingsworth MA; Imai K; Yonezawa S
Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841
[TBL] [Abstract][Full Text] [Related]
4. Influence of surgical margins on overall survival after resection of intrahepatic cholangiocarcinoma: A meta-analysis.
Tang H; Lu W; Li B; Meng X; Dong J
Medicine (Baltimore); 2016 Aug; 95(35):e4621. PubMed ID: 27583880
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomy.
Yeh CN; Pang ST; Wu RC; Chen TW; Jan YY; Chen MF
Oncol Rep; 2009 Jan; 21(1):49-56. PubMed ID: 19082442
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma.
Wu H; Liu Y; Jiang XW; Li WF; Guo G; Gong JP; Ding X
Tumour Biol; 2016 Oct; 37(10):13499-13508. PubMed ID: 27465555
[TBL] [Abstract][Full Text] [Related]
7. Clinical correlation of cadherin-17 marker with advanced tumor stages and poor prognosis of cholangiocarcinoma.
Zheng BH; Shen S; Wong KF; Gong ZJ; Sun WT; Ni XJ; Wang JW; Hu MY; Liu H; Ni XL; Liu HB; Luk JM; Suo T
J Surg Oncol; 2021 Apr; 123(5):1253-1262. PubMed ID: 33524213
[TBL] [Abstract][Full Text] [Related]
8. Association of mucin family members with prognostic significance in pancreatic cancer patients: A meta-analysis.
Xu W; Zhang M; Liu L; Yin M; Xu C; Weng Z
PLoS One; 2022; 17(6):e0269612. PubMed ID: 35709153
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of surgery for 2010 WHO classification-based intraductal papillary neoplasm of the bile duct: Case-control study of a single Japanese institution's experience with special attention to mucin expression patterns.
Harada F; Matsuyama R; Mori R; Kumamoto T; Morioka D; Taguri M; Yamanaka S; Endo I
Eur J Surg Oncol; 2019 May; 45(5):761-768. PubMed ID: 30389302
[TBL] [Abstract][Full Text] [Related]
10. MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma.
Tamada S; Shibahara H; Higashi M; Goto M; Batra SK; Imai K; Yonezawa S
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4257-64. PubMed ID: 16857800
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
12. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Platelet to Albumin Ratio Predicts Outcome of Patients with Cholangiocarcinoma.
Saito N; Shirai Y; Horiuchi T; Sugano H; Shiba H; Sakamoto T; Uwagawa T; Yanaga K
Anticancer Res; 2018 Feb; 38(2):987-992. PubMed ID: 29374731
[TBL] [Abstract][Full Text] [Related]
14. The expressions of HMGA2 and Thy1 in extrahepatic cholangiocarcinoma and their clinicopathological significances.
Liu R; Yang Z; Huang S; Li D; Zou Q; Yuan Y
Surg Oncol; 2019 Jun; 29():41-47. PubMed ID: 31196492
[TBL] [Abstract][Full Text] [Related]
15. Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma.
Ma MC; Chen YJ; Chiu TJ; Lan J; Liu CT; Chen YC; Tien HH; Chen YY
BMC Cancer; 2018 Feb; 18(1):227. PubMed ID: 29486735
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma.
Wakai T; Shirai Y; Sakata J; Matsuda Y; Korita PV; Takamura M; Ajioka Y; Hatakeyama K
Int J Clin Exp Pathol; 2011 Apr; 4(4):363-70. PubMed ID: 21577322
[TBL] [Abstract][Full Text] [Related]
17. Prognostic evaluation of mucin-5AC expression in intrahepatic cholangiocarcinoma, mass-forming type, following hepatectomy.
Abe T; Amano H; Shimamoto F; Hattori M; Kuroda S; Kobayashi T; Tashiro H; Ohdan H
Eur J Surg Oncol; 2015 Nov; 41(11):1515-21. PubMed ID: 26210654
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and Clinicopathological Significance of PD-L1 in Patients with Cholangiocarcinoma: A Meta-Analysis.
Xie Q; Wang L; Zheng S
Dis Markers; 2020; 2020():1817931. PubMed ID: 32724483
[TBL] [Abstract][Full Text] [Related]
19. CK7/CK19 index: A potential prognostic factor for postoperative intrahepatic cholangiocarcinoma patients.
Liu LZ; Yang LX; Zheng BH; Dong PP; Liu XY; Wang ZC; Zhou J; Fan J; Wang XY; Gao Q
J Surg Oncol; 2018 Jun; 117(7):1531-1539. PubMed ID: 29513894
[TBL] [Abstract][Full Text] [Related]
20. The effect of adjuvant chemotherapy in resectable cholangiocarcinoma: A meta-analysis and systematic review.
Wang ML; Ke ZY; Yin S; Liu CH; Huang Q
Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):110-116. PubMed ID: 30470543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]